|
|
Volumn 9, Issue 6, 2008, Pages 507-508
|
|
A smart move against cancer for vaccinia virus
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
JX 594;
VACCINIA VACCINE;
VIROTHERAPY AGENT;
ANTINEOPLASTIC ACTIVITY;
CANCER THERAPY;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ACCUMULATION;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG POTENCY;
DRUG SAFETY;
FLU LIKE SYNDROME;
HUMAN;
HYPERBILIRUBINEMIA;
HYPOTENSION;
LETTER;
LIVER TUMOR;
MAXIMUM TOLERATED DOSE;
MELANOMA;
NONHUMAN;
ONCOLYTIC VIROTHERAPY;
PRIORITY JOURNAL;
SKIN INFLAMMATION;
SKIN METASTASIS;
SMALLPOX;
TRANSGENE;
TUMOR IMMUNITY;
TUMOR REGRESSION;
VACCINIA VIRUS;
VIROTHERAPY;
VIRUS CELL INTERACTION;
VIRUS GENOME;
VIRUS REPLICATION;
ANIMALS;
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;
HUMANS;
HYPERBILIRUBINEMIA;
LIVER NEOPLASMS;
ONCOLYTIC VIROTHERAPY;
ONCOLYTIC VIRUSES;
POXVIRIDAE INFECTIONS;
TIME FACTORS;
TREATMENT FAILURE;
TREATMENT OUTCOME;
VACCINIA VIRUS;
VIRUS REPLICATION;
|
|
EID: 44349130904
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(08)70136-0 Document Type: Letter |
|
Times cited : (13)
|
|
References (5)
|
